Sanofi-aventis CEO Chris Viehbacher and Sanofi Pasteur President and CEO Wayne Pisano plan to discuss the challenges of manufacturing H1N1, or swine flu, vaccine, during a
webcast conference starting at 2:30 p.m. ET Wednesday, Nov. 11. David Greenberg, senior director of scientific and medical affairs at Sanofi Pasteur, will provide new data from adult and pediatric clinical trials of the U.S. licensed vaccine.